Site Map | Legal Policy | Privacy Policy

 

Email Alert Subscription

Step 1 of 3: Select Options

You may automatically receive Ligand Pharmaceuticals, Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here.

Press Releases
SEC Filings
  
  
  
Webcasts and Events
in advance of any event.
Stock Information
Send me a stock update at the end of the trading day.
Send me a stock update at the end of the week.
Alert me when the stock crosses the following price thresholds:
Current Stock Price is $3.450
    
Alert me when the stock changes more than % in one day.

Unsubscribe from Investor Relations email alerts.

Our email alerts provide automated opt-out methods as well as complete contact information.

For printed material, please contact Erika Luib in Investor Relations at 858-550-7896.

News

Ligand Pharmaceuticals Announces First Quarter Results

Ligand Initiates Phase II Trial with LGD-4665 in Idiopathic .......

Upcoming Events

Q1 2008 Ligand Pharmaceuticals Incorporated Earnings Confere...

Susquehanna Financial Group Second Annual SIGnificant Option...

Q4 2007 Ligand Pharmaceuticals Incorporated Earnings Confere...

Investor Relations|News|Presentations & Events|SEC Documents|
Corporate Governance|Email Alerts
LGND - (NASD)
$3.45   + 0.06